Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action (Q42525405)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

0 references

1 reference

based on heuristic

inferred from title

0 references

Jens Juul Holst

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Oluf Borbye Pedersen

object named as

O Pedersen

5

0 references

Knut Borch-Johnsen

6

object named as

K Borch-Johnsen

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

author name string

K Faerch

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

A Vaag

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

C Glümer

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

4 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

853-861

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin

1 reference

https://api.crossref.org/works/10.1007/S00125-008-0951-X

21 January 2018

Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1007/S00125-008-0951-X

21 January 2018

Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Who are more insulin resistant, people with IFG or people with IGT?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial associations of physical activity with 2-h but not fasting blood glucose in Australian adults: the AusDiab study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin secretion and action show differences in impaired fasting glucose and in impaired glucose tolerance in Asian Indians

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diminished Immunoreactive Gastric Inhibitory Polypeptide Response to a Meal in Newly Diagnosed Type I (Insulin-Dependent) Diabetics*

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired glucose tolerance and fasting hyperglycaemia have different characteristics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different contributions of insulin resistance and beta-cell dysfunction in overweight Israeli Arabs with IFG and IGT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brazilian individuals with impaired glucose tolerance are characterized by impaired insulin secretion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influences of glucose loading and of injected insulin on hepatic glucose output

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected].

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose clamp technique: a method for quantifying insulin secretion and resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced Incretin Effect in Type 2 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-008-0951-X

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42525405&oldid=2205477616"